206 related articles for article (PubMed ID: 15606330)
1. Management of muscle-invasive bladder cancer in the elderly.
Basso U; Bassi P; Sava T; Monfardini S
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1017-35. PubMed ID: 15606330
[TBL] [Abstract][Full Text] [Related]
2. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
Pansadoro V; Emiliozzi P
Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
[TBL] [Abstract][Full Text] [Related]
3. Treatment of muscle-invasive bladder cancer: progress and new challenges.
Herring JC; Kamat AM
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1047-56. PubMed ID: 15606332
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the treatment of bladder cancer.
Gwynn ES; Clark PE; Hall MC
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1023-30. PubMed ID: 16336093
[TBL] [Abstract][Full Text] [Related]
5. Organ-sparing treatment in muscle-invasive bladder cancer.
Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
[TBL] [Abstract][Full Text] [Related]
6. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
Parekh DJ; Bochner BH; Dalbagni G
J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
8. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
[TBL] [Abstract][Full Text] [Related]
9. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
Feneley MR; Mellon JK
Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
11. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
[TBL] [Abstract][Full Text] [Related]
12. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
13. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
Choueiri TK; Raghavan D
Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
16. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience.
Perdonà S; Autorino R; Damiano R; De Sio M; Morrica B; Gallo L; Silvestro G; Farella A; De Placido S; Di Lorenzo G
Cancer; 2008 Jan; 112(1):75-83. PubMed ID: 18008364
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer.
Dreicer R
Semin Urol Oncol; 2001 Aug; 19(3):180-5. PubMed ID: 11561985
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Herr HW
Eur Urol; 2008 Jul; 54(1):126-32. PubMed ID: 18248875
[TBL] [Abstract][Full Text] [Related]
19. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
20. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]